The Atopic Dermatitis and Novel Agents Comparative ... This trend was driven by upadacitinib compared with dupilumab (RR, 2.15; 95% CI, 1.01-4.56) whereas no significant difference in serious ...

A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...

Eli Lilly has two positive trials of its JAK inhibitor Olumiant in skin disorder atopic dermatitis (AD), which ... Sciences’ filgotinib and AbbVie’s upadacitinib. These are being developed ...

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from ... He also highlighted upadacitinib and abrocitinib, the oral ...

The drug is also being studied in other immune-mediated diseases – phase 3 trials of upadacitinib in atopic dermatitis, psoriatic arthritis, Crohn's disease, and ulcerative colitis are ongoing ...

Infections Higher With JAK Inhibitors in Eczema Study A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to ...

In adults with atopic dermatitis, moisturizers with anti-inflammatory ingredients significantly improved skin hydration and ...

The study was an open-label extension of two phase 3 studies. Response to upadacitinib was maintained, with responses of “similar magnitude” after switching from placebo. Upadacitinib sustains ...

AbbVie’s Rinvoq (upadacitinib) has been granted marketing authorisation by the European Commission (EC) to treat giant cell arteritis (GCA), making it the first oral Janus kinase (JAK) inhibitor to be ...

adults and adolescents with atopic dermatitis, and now adults with GCA. 2 *Sustained remission is defined as having an absence of GCA signs and symptoms from week 12 through week 52 and adherence ...

More New Zealanders will have access to medicines for blood cancers, bowel diseases, eczema and arthritis, following Pharmac’s decision to widen access to four medicines for six health conditions from ...